BACKGROUND: Leukocyte telomere length (LTL) chronicles the cumulative burden of oxidative stress and inflammation over a life course. Activation of the renin-angiotensin-aldosterone system is associated with increased oxidative stress and inflammation. Therefore, LTL may be related to circulating biomarkers of the renin-angiotensin-aldosterone system. METHODS AND RESULTS: We evaluated the cross-sectional relations of LTL (dependent variable) to circulating renin and aldosterone concentrations and the renin-to-aldosterone ratio (all logarithmically transformed; independent variables) in 1203 Framingham Study participants (mean age, 59 years; 51% women). We used multivariable linear regression and adjusted for age, blood pressure, hypertension treatment, smoking, diabetes mellitus, body mass index, hormone replacement therapy, serum creatinine, and the urine sodium-to-creatinine ratio. Overall, multivariable-adjusted LTL was inversely related to renin (beta coefficient per unit increase, -0.038; P=0.036), directly related to aldosterone (beta=0.099; P=0.002), and inversely related to the renin-to-aldosterone ratio (beta=-0.049; P=0.003). Relations of LTL to biomarkers were stronger in those with hypertension, although a formal test of interaction was not statistically significant (P=0.20). Individuals with hypertension displayed significant associations of LTL with renin (beta=-0.060; P=0.005), aldosterone (beta=0.134; P=0.002), and renin-to-aldosterone ratio (beta=-0.072; P<0.001). Participants with hypertension who were in the top tertile of the renin-to-aldosterone ratio had LTL that was 182 base pairs shorter relative to those in the lowest tertile. CONCLUSIONS: In our community-based sample, LTL was shorter in individuals with a higher renin-to-aldosterone ratio, especially in participants with hypertension. Additional investigations are warranted to confirm our observations.
BACKGROUND: Leukocyte telomere length (LTL) chronicles the cumulative burden of oxidative stress and inflammation over a life course. Activation of the renin-angiotensin-aldosterone system is associated with increased oxidative stress and inflammation. Therefore, LTL may be related to circulating biomarkers of the renin-angiotensin-aldosterone system. METHODS AND RESULTS: We evaluated the cross-sectional relations of LTL (dependent variable) to circulating renin and aldosterone concentrations and the renin-to-aldosterone ratio (all logarithmically transformed; independent variables) in 1203 Framingham Study participants (mean age, 59 years; 51% women). We used multivariable linear regression and adjusted for age, blood pressure, hypertension treatment, smoking, diabetes mellitus, body mass index, hormone replacement therapy, serum creatinine, and the urine sodium-to-creatinine ratio. Overall, multivariable-adjusted LTL was inversely related to renin (beta coefficient per unit increase, -0.038; P=0.036), directly related to aldosterone (beta=0.099; P=0.002), and inversely related to the renin-to-aldosterone ratio (beta=-0.049; P=0.003). Relations of LTL to biomarkers were stronger in those with hypertension, although a formal test of interaction was not statistically significant (P=0.20). Individuals with hypertension displayed significant associations of LTL with renin (beta=-0.060; P=0.005), aldosterone (beta=0.134; P=0.002), and renin-to-aldosterone ratio (beta=-0.072; P<0.001). Participants with hypertension who were in the top tertile of the renin-to-aldosterone ratio had LTL that was 182 base pairs shorter relative to those in the lowest tertile. CONCLUSIONS: In our community-based sample, LTL was shorter in individuals with a higher renin-to-aldosterone ratio, especially in participants with hypertension. Additional investigations are warranted to confirm our observations.
Authors: Frank Holger Perschel; Rudolf Schemer; Lysann Seiler; Martin Reincke; Jaap Deinum; Christiane Maser-Gluth; David Mechelhoff; Rudolf Tauber; Sven Diederich Journal: Clin Chem Date: 2004-07-09 Impact factor: 8.327
Authors: H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler Journal: N Engl J Med Date: 1972-03-02 Impact factor: 91.245
Authors: René A de Bruin; Angelique Bouhuizen; Sven Diederich; Frank H Perschel; Frans Boomsma; Jaap Deinum Journal: Clin Chem Date: 2004-11 Impact factor: 8.327
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Masayuki Kimura; Rivka C Stone; Steven C Hunt; Joan Skurnick; Xiaobin Lu; Xiaojian Cao; Calvin B Harley; Abraham Aviv Journal: Nat Protoc Date: 2010-09-02 Impact factor: 13.491
Authors: Lisa Mirabello; Wen-Yi Huang; Jason Y Y Wong; Nilanjan Chatterjee; Douglas Reding; E David Crawford; Immaculata De Vivo; Richard B Hayes; Sharon A Savage Journal: Aging Cell Date: 2009-06-01 Impact factor: 9.304
Authors: Abraham Aviv; Wei Chen; Jeffrey P Gardner; Masayuki Kimura; Michael Brimacombe; Xiaojian Cao; Sathanur R Srinivasan; Gerald S Berenson Journal: Am J Epidemiol Date: 2008-12-04 Impact factor: 4.897
Authors: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen Journal: Clin Res Cardiol Date: 2009-07-15 Impact factor: 5.460
Authors: Steven C Hunt; Wei Chen; Jeffrey P Gardner; Masayuki Kimura; Sathanur R Srinivasan; John H Eckfeldt; Gerald S Berenson; Abraham Aviv Journal: Aging Cell Date: 2008-05-02 Impact factor: 9.304